- 全部删除
- 您的购物车当前为空
Keap1-Nrf2-IN-21 (compound 4d) 为具有抗肿瘤活性的糖代谢抑制剂.此化合物通过靶向糖酵解途径,尤其是通过干预Keap1-Nrf2信号通路,有效抑制癌细胞糖酵解活性,进而抑制其肿瘤生长.在HEC1A细胞系中,Keap1-Nrf2-IN-21 展现出显著的细胞毒性效力 (IC50=2.60 μM).
Keap1-Nrf2-IN-21 (compound 4d) 为具有抗肿瘤活性的糖代谢抑制剂.此化合物通过靶向糖酵解途径,尤其是通过干预Keap1-Nrf2信号通路,有效抑制癌细胞糖酵解活性,进而抑制其肿瘤生长.在HEC1A细胞系中,Keap1-Nrf2-IN-21 展现出显著的细胞毒性效力 (IC50=2.60 μM).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 待询 | |
50 mg | 待询 | 待询 |
Keap1-Nrf2-IN-21 相关产品
产品描述 | Keap1-Nrf2-IN-21 (compound 4d) acts as an inhibitor of glucose metabolism with anti-tumoral properties. It targets the glycolytic pathway by affecting the Keap1-Nrf2 signaling pathway, which in turn suppresses glycolytic activity in cancer cells and inhibits tumor growth. Additionally, Keap1-Nrf2-IN-21 exhibits cytotoxic effects on the HEC1A cell line with an IC50 value of 2.60 μM. |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容